Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad Reports Full Year 2019 Financial Results And Provides Business Update

Celyad SA  CYAD.BR :
    * CELYAD REPORTS FULL YEAR 2019 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * NKG2D CAR-T CLINICAL CANDIDATE CYAD-01 CONTINUES TO
ADVANCE IN
PHASE 1 TRIALS FOR TREATMENT OF PATIENTS WITH R/R AML OR MDS
    * CELYAD -CO NOT CURRENTLY EXPERIENCING ANY MAJOR
DISRUPTIONS IN
ITS BUSINESS RELATED TO COVID-19

Source text for Eikon:  ID:nGNX1yW61p 
Further company coverage:  CYAD.BR

Recent news on Celyad Oncology SA

See all news